Schematic overview of the cellular and molecular mechanisms involved in the cancer progression, including the proposed cellular and molecular mechanisms in cancer cells trajectory. AT1: alveolar type 1 cells; AT2: alveolar type 2 cells; AAH: atypical adenomatous hyperplasia; AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma; IA: invasive adenocarcinoma; EMT: epithelial-mesenchymal transition

Home

Download

Statistics

Help

Contact

	Gene summary
	Malignant transformation analysis
	Malignant transformation related pathway analysis
	Cell-cell communication analysis
	Single-cell gene regulatory network inference analysis
	Somatic mutation of malignant transformation related genes
	Related drugs of malignant transformation related genes

Gene: COX7A2

Gene summary for COX7A2

Gene summary.

Gene information	Species	Human
	Gene symbol	COX7A2
	Gene ID	1347
	Gene name	cytochrome c oxidase subunit 7A2
	Gene Alias	COX7AL
	Cytomap	6q14.1
	Gene Type	protein-coding
	GO ID	GO:0002082
	UniProtAcc	H0UI06

Top

Malignant transformation analysis

Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells

Malignant transformation involving gene list.

Entrez ID	Symbol	Replicates	Species	Organ	Tissue	Adj P-value	Log2FC	Malignancy
1347	COX7A2	GSM4909280	Human	Breast	Precancer	2.05e-04	-5.68e-01	0.0305
1347	COX7A2	GSM4909281	Human	Breast	IDC	4.23e-74	6.24e-01	0.21
1347	COX7A2	GSM4909282	Human	Breast	IDC	3.37e-38	4.36e-01	-0.0288
1347	COX7A2	GSM4909285	Human	Breast	IDC	2.54e-06	2.91e-01	0.21
1347	COX7A2	GSM4909286	Human	Breast	IDC	3.77e-03	1.64e-01	0.1081
1347	COX7A2	GSM4909287	Human	Breast	IDC	5.61e-17	1.97e-01	0.2057
1347	COX7A2	GSM4909288	Human	Breast	IDC	4.15e-06	-2.24e-02	0.0988
1347	COX7A2	GSM4909290	Human	Breast	IDC	2.60e-16	3.35e-01	0.2096
1347	COX7A2	GSM4909293	Human	Breast	IDC	5.65e-04	2.60e-01	0.1581
1347	COX7A2	GSM4909294	Human	Breast	IDC	3.25e-23	7.36e-02	0.2022
1347	COX7A2	GSM4909296	Human	Breast	IDC	5.13e-11	-1.22e-01	0.1524
1347	COX7A2	GSM4909297	Human	Breast	IDC	5.80e-38	9.12e-02	0.1517
1347	COX7A2	GSM4909298	Human	Breast	IDC	1.88e-15	3.76e-01	0.1551
1347	COX7A2	GSM4909300	Human	Breast	IDC	6.37e-03	2.12e-01	0.0334
1347	COX7A2	GSM4909301	Human	Breast	IDC	3.32e-79	6.30e-01	0.1577
1347	COX7A2	GSM4909302	Human	Breast	IDC	5.14e-05	-6.97e-03	0.1545
1347	COX7A2	GSM4909306	Human	Breast	IDC	5.30e-38	4.94e-01	0.1564
1347	COX7A2	GSM4909307	Human	Breast	IDC	9.47e-37	4.48e-01	0.1569
1347	COX7A2	GSM4909308	Human	Breast	IDC	2.53e-24	3.96e-01	0.158
1347	COX7A2	GSM4909309	Human	Breast	IDC	6.43e-05	-2.24e-02	0.0483

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Transcriptomic changes along malignancy continuum.

Tissue	Expression Dynamics	Abbreviation
Breast		IDC: Invasive ductal carcinoma
		DCIS: Ductal carcinoma in situ
		Precancer(BRCA1-mut): Precancerous lesion from BRCA1 mutation carriers
Cervix		CC: Cervix cancer
		HSIL_HPV: HPV-infected high-grade squamous intraepithelial lesions
		N_HPV: HPV-infected normal cervix
Colorectum (GSE201348)		FAP: Familial adenomatous polyposis
		CRC: Colorectal cancer
Colorectum (HTA11)		AD: Adenomas
		SER: Sessile serrated lesions
		MSI-H: Microsatellite-high colorectal cancer
		MSS: Microsatellite stable colorectal cancer
Endometrium		AEH: Atypical endometrial hyperplasia
		EEC: Endometrioid Cancer
Esophagus		ESCC: Esophageal squamous cell carcinoma
		HGIN: High-grade intraepithelial neoplasias
		LGIN: Low-grade intraepithelial neoplasias
GC		CAG: Chronic atrophic gastritis
		CAG with IM: Chronic atrophic gastritis with intestinal metaplasia
		CSG: Chronic superficial gastritis
		GC: Gastric cancer
		SIM: Severe intestinal metaplasia
		WIM: Wild intestinal metaplasia
Liver		HCC: Hepatocellular carcinoma
		NAFLD: Non-alcoholic fatty liver disease
Lung		AAH: Atypical adenomatous hyperplasia
		AIS: Adenocarcinoma in situ
		IAC: Invasive lung adenocarcinoma
		MIA: Minimally invasive adenocarcinoma
Oral Cavity		EOLP: Erosive Oral lichen planus
		LP: leukoplakia
		NEOLP: Non-erosive oral lichen planus
		OSCC: Oral squamous cell carcinoma
Prostate		BPH: Benign Prostatic Hyperplasia
Skin		AK: Actinic keratosis
		cSCC: Cutaneous squamous cell carcinoma
		SCCIS:squamous cell carcinoma in situ
Thyroid		ATC: Anaplastic thyroid cancer
		HT: Hashimoto's thyroiditis
		PTC: Papillary thyroid cancer

∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.

Top

Malignant transformation related pathway analysis

Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer

Figure of enriched GO biological processes.

Tissue	Disease Stage	Enriched GO biological Processes
Colorectum	AD
Colorectum	SER
Colorectum	MSS
Colorectum	MSI-H
Colorectum	FAP

∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).

Page: 1 2 3 4 5 6 7 8 9

Enriched GO biological processes.

GO ID	Tissue	Disease Stage	Description	Gene Ratio	Bg Ratio	pvalue	p.adjust	Count
GO:004277314	Cervix	HSIL_HPV	ATP synthesis coupled electron transport	15/737	95/18723	4.31e-06	1.70e-04	15
GO:004277514	Cervix	HSIL_HPV	mitochondrial ATP synthesis coupled electron transport	15/737	95/18723	4.31e-06	1.70e-04	15
GO:002290414	Cervix	HSIL_HPV	respiratory electron transport chain	15/737	114/18723	4.08e-05	1.08e-03	15
GO:004533314	Cervix	HSIL_HPV	cellular respiration	23/737	230/18723	4.13e-05	1.09e-03	23
GO:000612313	Cervix	HSIL_HPV	mitochondrial electron transport, cytochrome c to oxygen	6/737	21/18723	1.19e-04	2.42e-03	6
GO:002290014	Cervix	HSIL_HPV	electron transport chain	18/737	175/18723	1.93e-04	3.56e-03	18
GO:001598014	Cervix	HSIL_HPV	energy derivation by oxidation of organic compounds	24/737	318/18723	1.84e-03	1.96e-02	24
GO:000609114	Cervix	HSIL_HPV	generation of precursor metabolites and energy	32/737	490/18723	3.69e-03	3.27e-02	32
GO:0046034	Colorectum	AD	ATP metabolic process	142/3918	277/18723	2.64e-29	8.26e-26	142
GO:0006091	Colorectum	AD	generation of precursor metabolites and energy	209/3918	490/18723	3.17e-28	6.61e-25	209
GO:0009060	Colorectum	AD	aerobic respiration	108/3918	189/18723	9.14e-28	1.43e-24	108
GO:0045333	Colorectum	AD	cellular respiration	119/3918	230/18723	3.21e-25	4.02e-22	119
GO:0006119	Colorectum	AD	oxidative phosphorylation	83/3918	141/18723	7.95e-23	8.30e-20	83
GO:0015980	Colorectum	AD	energy derivation by oxidation of organic compounds	143/3918	318/18723	2.78e-22	2.49e-19	143
GO:0022900	Colorectum	AD	electron transport chain	89/3918	175/18723	1.42e-18	8.91e-16	89
GO:0019646	Colorectum	AD	aerobic electron transport chain	53/3918	87/18723	5.58e-16	2.16e-13	53
GO:0042773	Colorectum	AD	ATP synthesis coupled electron transport	56/3918	95/18723	6.76e-16	2.22e-13	56
GO:0042775	Colorectum	AD	mitochondrial ATP synthesis coupled electron transport	56/3918	95/18723	6.76e-16	2.22e-13	56
GO:0022904	Colorectum	AD	respiratory electron transport chain	63/3918	114/18723	8.23e-16	2.45e-13	63
GO:1902600	Colorectum	AD	proton transmembrane transport	66/3918	157/18723	1.59e-09	1.17e-07	66

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Enriched KEGG pathways.

Pathway ID	Tissue	Disease Stage	Description	Gene Ratio	Bg Ratio	pvalue	p.adjust	qvalue	Count
hsa0501218	Breast	Precancer	Parkinson disease	99/684	266/8465	3.58e-42	5.65e-40	4.33e-40	99
hsa0502016	Breast	Precancer	Prion disease	95/684	273/8465	1.39e-37	1.46e-35	1.12e-35	95
hsa0501616	Breast	Precancer	Huntington disease	98/684	306/8465	2.85e-35	2.25e-33	1.72e-33	98
hsa0019016	Breast	Precancer	Oxidative phosphorylation	59/684	134/8465	6.15e-30	3.24e-28	2.48e-28	59
hsa0501016	Breast	Precancer	Alzheimer disease	103/684	384/8465	1.03e-29	4.66e-28	3.57e-28	103
hsa0501416	Breast	Precancer	Amyotrophic lateral sclerosis	98/684	364/8465	2.13e-28	8.41e-27	6.44e-27	98
hsa0502216	Breast	Precancer	Pathways of neurodegeneration - multiple diseases	112/684	476/8465	6.96e-27	2.44e-25	1.87e-25	112
hsa0520818	Breast	Precancer	Chemical carcinogenesis - reactive oxygen species	68/684	223/8465	3.61e-23	1.14e-21	8.73e-22	68
hsa0471418	Breast	Precancer	Thermogenesis	68/684	232/8465	4.40e-22	1.26e-20	9.69e-21	68
hsa0541518	Breast	Precancer	Diabetic cardiomyopathy	63/684	203/8465	5.63e-22	1.48e-20	1.14e-20	63
hsa0493216	Breast	Precancer	Non-alcoholic fatty liver disease	48/684	155/8465	6.16e-17	1.50e-15	1.15e-15	48
hsa0426016	Breast	Precancer	Cardiac muscle contraction	22/684	87/8465	9.72e-07	1.62e-05	1.24e-05	22
hsa0501219	Breast	Precancer	Parkinson disease	99/684	266/8465	3.58e-42	5.65e-40	4.33e-40	99
hsa0502017	Breast	Precancer	Prion disease	95/684	273/8465	1.39e-37	1.46e-35	1.12e-35	95
hsa0501617	Breast	Precancer	Huntington disease	98/684	306/8465	2.85e-35	2.25e-33	1.72e-33	98
hsa0019017	Breast	Precancer	Oxidative phosphorylation	59/684	134/8465	6.15e-30	3.24e-28	2.48e-28	59
hsa0501017	Breast	Precancer	Alzheimer disease	103/684	384/8465	1.03e-29	4.66e-28	3.57e-28	103
hsa0501417	Breast	Precancer	Amyotrophic lateral sclerosis	98/684	364/8465	2.13e-28	8.41e-27	6.44e-27	98
hsa0502217	Breast	Precancer	Pathways of neurodegeneration - multiple diseases	112/684	476/8465	6.96e-27	2.44e-25	1.87e-25	112
hsa0520819	Breast	Precancer	Chemical carcinogenesis - reactive oxygen species	68/684	223/8465	3.61e-23	1.14e-21	8.73e-22	68

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Top

Cell-cell communication analysis

Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states

Ligand

Receptor

LRpair

Pathway

Tissue

Disease Stage

Page: 1

Top

Single-cell gene regulatory network inference analysis

Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states

Cell Type

Tissue

Disease Stage

Target Gene

RSS

Regulon Activity

∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.

Page: 1

Top

Somatic mutation of malignant transformation related genes

Annotation of somatic variants for genes involved in malignant transformation

Hugo Symbol

Variant Class

Variant Classification

dbSNP RS

HGVSc

HGVSp

HGVSp Short

SWISSPROT

BIOTYPE

SIFT

PolyPhen

Tumor Sample Barcode

Tissue

Histology

Sex

Age

Stage

Therapy Types

Drugs

Outcome

COX7A2

insertion

Frame_Shift_Ins

novel

c.20_21insCCCTGTC

p.Glu7AspfsTer53

p.E7Dfs*53

protein_coding

TCGA-A2-A0CP-01

Breast

breast invasive carcinoma

Female

<65

I/II

Chemotherapy

cytoxan

COX7A2

insertion

Nonsense_Mutation

novel

c.19_20insGTTAGACCCGTCTTGGGTTCTTAGTCACCACCTCTA

p.Glu7delinsGlyTerThrArgLeuGlyPheLeuValThrThrSerLys

p.E7delinsG*TRLGFLVTTSK

protein_coding

TCGA-A2-A0CP-01

Breast

breast invasive carcinoma

Female

<65

I/II

Chemotherapy

cytoxan

COX7A2

SNV

Missense_Mutation

rs531403377

c.34C>T

p.Pro12Ser

p.P12S

protein_coding

deleterious_low_confidence(0.01)

benign(0.015)

TCGA-UC-A7PF-01

Cervix

cervical & endocervical cancer

Female

<65

I/II

Unknown

COX7A2

SNV

Missense_Mutation

rs762527604

c.38N>T

p.Ala13Val

p.A13V

protein_coding

deleterious_low_confidence(0.03)

benign(0.011)

TCGA-EI-7002-01

Colorectum

rectum adenocarcinoma

Male

<65

III/IV

Chemotherapy

irinotecan+5-fluorouracilim

COX7A2

insertion

Frame_Shift_Ins

novel

c.195_196insA

p.Leu66ThrfsTer6

p.L66Tfs*6

protein_coding

TCGA-AD-6964-01

Colorectum

colon adenocarcinoma

Male

<65

III/IV

Chemotherapy

folfox

COX7A2

SNV

Missense_Mutation

rs750678578

c.140N>T

p.Thr47Met

p.T47M

protein_coding

deleterious(0)

probably_damaging(0.959)

TCGA-A5-A0G2-01

Endometrium

uterine corpus endometrioid carcinoma

Female

<65

III/IV

Unknown

COX7A2

SNV

Missense_Mutation

rs759302783

c.137N>A

p.Arg46Lys

p.R46K

protein_coding

deleterious(0.02)

benign(0.232)

TCGA-A5-A1OF-01

Endometrium

uterine corpus endometrioid carcinoma

Female

<65

I/II

Unknown

COX7A2

SNV

Missense_Mutation

novel

c.96G>T

p.Lys32Asn

p.K32N

protein_coding

tolerated(0.07)

benign(0.264)

TCGA-AX-A05Z-01

Endometrium

uterine corpus endometrioid carcinoma

Female

<65

III/IV

Chemotherapy

adriamycin

COX7A2

SNV

Missense_Mutation

novel

c.85G>A

p.Val29Ile

p.V29I

protein_coding

tolerated_low_confidence(0.34)

benign(0)

TCGA-B5-A1MX-01

Endometrium

uterine corpus endometrioid carcinoma

Female

<65

I/II

Hormone Therapy

megace

Page: 1

Top

Related drugs of malignant transformation related genes

Identification of chemicals and drugs interact with genes involved in malignant transfromation

(DGIdb 4.0)

Entrez ID

Symbol

Category

Interaction Types

Drug Claim Name

Drug Name

PMIDs

Page: 1